BDNF and depressive symptom measurement: Central and peripheral levels of BDNF expression are lower in patients with MS and depression and this may be exacerbated during infection with COVID-19, as supported by findings that anti-depressant treatments and exercise training raise BDNF levels (White and Castellano, 2008; Silverman and Deuster, 2014).